![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Farkad Ezzet David Wexler Rachel Courtney Gopal Krishna Josephine Lim Mark Laughlin
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.44, Iss.2, 2005-01, pp. : 211-220
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
American Journal of Cardiovascular Drugs, Vol. 11, Iss. 5, 2011-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bioavailability of valsartan oral dosage forms
Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Pokrajac M. Miljkovic B. Simic D. Brzakovic B. Galetin A.
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 43, Iss. 2, 1997-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Staab A. Schug B.S. Larsimont V. Elze M. Thummler D. Mutschler E. Blume H.
European Journal of Pharmaceutical Sciences, Vol. 18, Iss. 2, 2003-02 ,pp. :